SCHEMBL23502591

SCHEMBL23502591

CCCCCCC(C)(CC)c1cnc2cc(C(C)(CC)CCC)cc(F)c2n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20047619 0.91 CNR2 (0.32) —
SCHEMBL23502571 0.91 TLR7 (0.32) —
SCHEMBL20047686 0.85 CNR2 (0.34) —
SCHEMBL23502553 0.84 CNR1 (0.33) —
SCHEMBL23502550 0.83 PDE4A (0.31) —
SCHEMBL23502576 0.83 — —
SCHEMBL20047627 0.82 TLR8 (0.32) —
SCHEMBL23502551 0.81 CNR2 (0.38) —
SCHEMBL20047622 0.78 CNR2 (0.31) —
SCHEMBL20047498 0.77 CNR2 (0.33) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11034684-B2 Isoxazole analogs as FXR agonists and methods of use thereof ENANTA PHARMACEUTICALS, INC. (US) 2021-06-15 — — US disclosed
Send feedback